Access to peer-reviewed cannabis research through established academic publishers like Sage represents a maturation of the field that directly benefits clinicians seeking evidence-based guidance. Quality research publication pathways are essential for translating laboratory findings into clinical practice recommendations.
Cannabis & Cannabinoid Research journal, published by Sage, provides a dedicated venue for peer-reviewed research in cannabis medicine and science. The journal covers preclinical studies, clinical trials, pharmacology, and therapeutic applications across the spectrum of cannabis and cannabinoid research. This represents part of the growing academic infrastructure supporting evidence-based cannabis medicine as the field transitions from anecdotal reporting to rigorous scientific investigation.
“Having established publishers like Sage host dedicated cannabis journals signals that we’re moving past the ‘wild west’ phase of cannabis research into legitimate academic medicine. This gives clinicians a trusted source for peer-reviewed findings rather than relying on conference abstracts or industry-funded studies.”
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
FAQ
What is the CED Clinical Relevance rating system?
The CED Clinical Relevance system appears to be a classification method used by CED Clinic to categorize medical research and developments. Rating #70 indicates “Notable Clinical Interest” for emerging findings or policy developments that warrant close monitoring by healthcare professionals.
What type of medical content does this relate to?
This content is specifically related to cannabis medicine and research. It falls under the CED Clinic’s cannabis news section, focusing on evidence-based medical applications and clinical practice developments in this field.
What research areas are covered in this publication?
The content covers multiple research domains including evidence-based medicine, clinical practice applications, and academic publishing. These areas suggest a comprehensive approach to cannabis-related medical research and its practical implementation in healthcare settings.
Who is the target audience for this information?
The target audience appears to be healthcare professionals, researchers, and clinicians interested in cannabis medicine. The clinical relevance rating and evidence-based focus indicate it’s designed for medical practitioners seeking current developments in this specialized field.
How current is this information?
This information is marked as “New” indicating recent publication or updates. The classification as “emerging findings” suggests this represents the latest developments in cannabis medicine research and clinical applications.
Read next
